Heart failure affects the heart’s ability to pump blood efficiently, leading to symptoms like fatigue and shortness of breath. Today, it impacts 6.7 million Americans over 20 years old, with that number expected to climb to 8.5 million by 2030.
The John Ochsner Heart & Vascular Institute is a leader in advanced heart failure treatment through technologies like Left Ventricular Assist Devices (LVADs). Filling a gap between diagnosis and donor wait times, LVADs not only improve immediate blood flow, but they also serve as a sustainable solution for those who are not transplant candidates.
During Heart Month, Ochsner Health seeks to empower individuals and create healthier communities. We’re available for expert interviews about heart health, heart failure, and other topics.
